ilmscore | Prediction Details
"the company won't be able to launch the drug until December 2026, when the US company Incyte's patent expires."
By Groww | November 4, 2024 | Pending
From video
Why did Sun Pharma fall by 4%? #shorts 00:00:38 - 00:00:43
Interpreted Prediction
Sun Pharma's Lavi tablet launch in the US is predicted to be delayed until December 2026 due to patent expiration.

Prediction Details

Topic
Sun Pharma's Lavi tablet launch

Comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.